PR Newswire - Results from #536

First Patient Enrolled in SELUTION SLR(TM) SUCCESS PTA Study

First Patient Enrolled in SELUTION SLR(TM) SUCCESS PTA Study

NYON, Switzerland, Feb. 11, 2021 /PRNewswire/ -- MedAlliance has announced enrolment of the first patient in SUCCESS PTA, its large post-market study with the drug-eluting balloon SELUTION SLR™ for the treatment of patients with peripheral artery disease (PAD). SELUTION SLR is a novel sirolimus-eluting balloon that provides a controlled...

Read more: First Patient Enrolled in SELUTION SLR(TM) SUCCESS PTA Study

More Articles …

'Supercharger' to revive mainstay antibiotic in global fight against antibiotic resistance
Socialsuite strengthens North American expansion with two executive appointments
$16 Million Capital Raise to Progress Bionomics BNC210 PTSD Trial
Toyota Material Handling Reimagines Dealer Engagement on Infosys Platform
CardiacSense Medical Grade Watch receives CE Mark for continuous detection of Atrial Fibrillation
Randstad RiseSmart continues to drive expansion and growth across Asia Pacific, the Middle East and Africa with key leadership appointments
China National Medical Products Administration Approves MR-guided Focused Ultrasound To Treat Essential Tremor And Tremor-dominant Parkinson's Disease
Shaking Up the Rental Sector: Hmlet Opens Second Western Sydney Site
Sasol reuses wax from spent catalysts as part of commitment to responsible production and consumption
Exclaimer Acquires Customer Thermometer to Bring Real-Time Customer Feedback to its Global Corporate Email Signature Platform

Start
Prev
532
533
534
Next
End
Page 537 of 1179